Revolution Medicines, Inc. (RVMD) Institutional Ownership

Institutions by Trading Activity

Ownership Statistics

185,516,988Shares Outstanding

22,444,188Shares held by institutions

$2,258,109,755Value of institutional holdings

104.96%Institutional ownership %

3.93%Shares Changed QoQ

369No. of institutional investors

Shares Owned by Institutions

Shares Purchased/Sold by Institutions

Ownership Summary

According to SEC filings for the period ending December 2025, Revolution Medicines, Inc. (NASDAQ:RVMD) is held by 369 institutional firms.

These investors collectively held 105.0% of the company's total shares outstanding in December 2025, up from 104.1% in September 2025.
Quarterly data indicates a 3.93% shift in institutional share volume, and the annual owner count reflects an increase of 32.73%.
During the quarter, 229 institutions bought more Revolution Medicines shares, 98 sold shares, and 42 of the 369 total investors held their position steady.
The aggregate institutional position in Revolution Medicines now stands at 194.72Mn shares as of December 2025, after investors increased their holdings (up by 7.36Mn shares quarter on quarter which is up 1.08Mn shares year over year).
As of December 31, 2025, VANGUARD GROUP INC held Revolution Medicines's largest shareholding position with over 16.72Mn shares, representing 9.01% of total outstanding shares.
Among the most significant buyers of Revolution Medicines during December 2025 were NORGES BANK (2.46Mn), Avoro Capital Advisors LLC (2.17Mn), UBS Group AG (2.00Mn), GOLDMAN SACHS GROUP INC (1.75Mn), Polar Capital Holdings Plc (1.54Mn).
Leading sellers of Revolution Medicines stock in December 2025 included T. Rowe Price Investment Management, Inc. (3.48Mn), WELLINGTON MANAGEMENT GROUP LLP (2.83Mn), JPMORGAN CHASE & CO (2.08Mn), a16z Capital Management, L.L.C. (1.83Mn), Holocene Advisors, LP (1.53Mn).
The top 10 institutional holders of Revolution Medicines for the quarter ending December 2025 included VANGUARD GROUP INC (16.72Mn), FARALLON CAPITAL MANAGEMENT LLC (14.58Mn), JANUS HENDERSON GROUP PLC (12.30Mn), BAKER BROS. ADVISORS LP (9.46Mn), BlackRock, Inc. (8.93Mn), FMR LLC (8.59Mn), Nextech Invest, Ltd. (7.60Mn), WELLINGTON MANAGEMENT GROUP LLP (6.99Mn), Paradigm Biocapital Advisors LP (6.64Mn), Bellevue Group AG (5.01Mn).

369 Institutional Holders

22,444,188 Total Shares Held

Rows:

Download Data

Owner Name	Date	Shares Held	Change (QoQ)	Change (%)	Value (USD)
VANGUARD GROUP INC	31 Dec, 2025	16,719,886	1,056,792	6.75%	$1,331,738,920.00
FARALLON CAPITAL MANAGEMENT LLC	31 Dec, 2025	14,582,796	-42,896	-0.29%	$1,161,519,701.00
JANUS HENDERSON GROUP PLC	31 Dec, 2025	12,303,502	947,448	8.34%	$980,035,989.00
BAKER BROS. ADVISORS LP	31 Dec, 2025	9,455,357	0	0.00%	$753,119,185.00
BlackRock, Inc.	31 Dec, 2025	8,926,656	598,898	7.19%	$711,008,150.00
FMR LLC	31 Dec, 2025	8,587,981	-813,706	-8.65%	$684,032,699.00
Nextech Invest, Ltd.	31 Dec, 2025	7,601,087	0	0.00%	$605,426,580.00
WELLINGTON MANAGEMENT GROUP LLP	31 Dec, 2025	6,987,639	-2,825,797	-28.80%	$556,565,446.00
Paradigm Biocapital Advisors LP	31 Dec, 2025	6,644,403	421,112	6.77%	$529,226,699.00
Bellevue Group AG	31 Dec, 2025	5,005,719	-568,119	-10.19%	$398,705,518.00
STATE STREET CORP	31 Dec, 2025	4,109,290	-1,145,349	-21.80%	$327,304,949.00
BVF INC/IL	31 Dec, 2025	3,356,782	-618,131	-15.55%	$267,367,686.00
Alphabet Inc.	31 Dec, 2025	3,345,102	-788,175	-19.07%	$266,437,374.00
GEODE CAPITAL MANAGEMENT, LLC	31 Dec, 2025	3,161,963	16,323	0.52%	$251,911,578.00
UBS Group AG	31 Dec, 2025	3,087,937	1,998,972	183.57%	$245,954,181.00
DEERFIELD MANAGEMENT COMPANY, L.P.	31 Dec, 2025	2,894,613	-755,729	-20.70%	$230,555,925.00
WESTFIELD CAPITAL MANAGEMENT CO LP	31 Dec, 2025	2,845,013	331,046	13.17%	$226,605,319.00
GENERAL ATLANTIC, L.P.	31 Dec, 2025	2,812,928	338,500	13.68%	$224,049,715.00
Casdin Capital, LLC	31 Dec, 2025	2,577,333	-70,000	-2.64%	$205,284,573.00
GOLDMAN SACHS GROUP INC	31 Dec, 2025	2,512,274	1,753,248	230.99%	$200,102,624.00

1 - 20 of 369

Research Tools